Obesity - Novo Nordisk
As leaders within the science of obesity, we are working to make obesity a healthcare priority, defeat stigma and support better access to evidence-based care. Scientific and medical …
The Science Behind Obesity | Novo Nordisk U.S.
As leaders in the science of obesity, we are working to make obesity a healthcare priority, defeat stigma and support better access to evidence-based care. We aim to be the leading force in …
Our mission to defeat obesity - Novo Nordisk
We are on a mission to increase awareness about obesity and its causes, destigmatise this chronic disease, and provide diverse treatment options. We are working towards a future …
Transformational Prevention Unit - Novo Nordisk
As leaders within the science of obesity, Novo Nordisk established the Transformational Prevention Unit (TPU) to tackle one of the world’s foremost health challenges and drive …
Novo Nordisk says its obesity drug in higher dose shows 20.7
15 hours ago · Novo Nordisk said a higher dose of its drug Wegovy led to greater weight loss in patients during a late-stage trial, but the results fell short of the weight loss achieved with Eli …
Driving Change in Obesity | Novo Nordisk U.S.
At Novo Nordisk, we are dedicated to making obesity a healthcare priority. We are committed to helping improve the lives of people with obesity by changing how the world sees, prevents and …
Novo Nordisk® is Committed to the Management of Obesity - Rethink Obesity
Novo Nordisk® is committed to discovering, developing, and delivering resources and tools to help enhance weight-loss discussion and motivate healthy changes.
FORWARD Obesity Education Curriculum - Scientific Exchange
FORWARD was developed by Novo Nordisk Inc., in collaboration with a steering committee of obesity clinician experts, to address gaps in obesity education and support the preparation of …
Rethink Obesity® HCP Educational Website
Visit Rethink Obesity® to learn how obesity may affect patients and get tools to support their weight management. Novo Nordisk Commitment Patient Site
News details - Novo Nordisk
Jun 4, 2021 · Novo Nordisk receives FDA approval for Wegovy™ to treat adults with obesity based on unprecedented efficacy for a prescription medicine in clinical trials - Despite being …